Advertisement

Advertisement

2016 ASH Annual Meeting

Advertisement

Advertisement



Apr
10
Today In Oncology
Pre–Salvage Radiotherapy PSA Levels and Outcomes With Long-Term Antiandrogen Therapy in Prostate Cancer
Cancer Care in the Time of COVID-19 Statement From Fox Chase Cancer Center
Trastuzumab Beyond Progression in HER2-Positive Advanced Gastric/Gastroesophageal Junction Cancer
Apixaban for Cancer-Associated VTE
FDA Pipeline Approval of New Dosing for Biosimilar, Plus Two Fast Track Designations
View More 
Advertisement
Most Read Stories
Mitigating the Spread of COVID-19 and Its Impact on Cancer
Clinical Trials to Evaluate Activity of Biologics, Other Agents Against COVID-19
Continuous Coverage of COVID-19
ASH Research Collaborative's Data Hub Creates International Data Registry for Patients With Blood Cancers and COVID-19
When Can Patients With Gleason 6 Prostate Cancer Safely Undergo Active Surveillance?
View More 
Most Viewed Videos
Sara M. Tolaney, MD, MPH, on HER2-Positive Breast Cancer: ATEMPT Trial on T-DM1 vs Paclitaxel Plus Trastuzumab
Pirkko-Liisa Irmeli Kellokumpu-Lehtinen, MD, PhD, on Prostate Cancer: Results of the SPCG-13 Trial
Jeffrey A. Meyerhardt, MD, MPH, on Colon Cancer: Results From the ACTS-CC 02 Trial on Adjuvant Chemotherapy
Solange Peters, MD, PhD, on NSCLC: CheckMate 227 Trial of Nivolumab/Ipilimumab vs Chemotherapy
William J. Gradishar, MD, on HR-Positive, HER2-Negative Advanced Breast Cancer: NCCN Guidelines Updates
View More 
© 2020 HSP News Service, L.L.C.